Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29 (ShorTrip)

NCT05253846 PHASE2 ACTIVE_NOT_RECRUITING

The aim of the ShorTrip trail is to evaluate the activity and the safety of total neoadjuvant strategy with FOLFOXIRI as consolidation therapy preceded by short-course radiotherapy and followed by surgery in LARC patients.

Details

Lead sponsor	Gruppo Oncologico del Nord-Ovest
Phase	PHASE2
Status	ACTIVE_NOT_RECRUITING
Enrolment	63
Start date	Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Oct 30 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Locally Advanced Rectal Cancer

Interventions

• Irinotecan
• Oxaliplatin
• Lederfolin
• 5-Fluorouracil
• Short-course radiotherapy
• TME

Countries

Italy